Roundhill GLP-1 & Weight Loss ETF Rating $21.50 -1.37 (-5.99%) As of 04/4/2025 03:48 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.OZEM Aggregate RatingModerate Buy 2.84Holdings in OZEM have an aggregate rating of Moderate Buy based on 223 analyst ratings issued in the past year covering 18 companies (66.7% of the portfolio).OZEM Aggregate Price Target$21.50High Prediction$21.50Average Prediction$21.50Low Prediction$21.50Holdings in OZEM have an aggregate price target of $21.50 and a range of $21.50 to $21.50 covering 18 companies (66.7% of the portfolio).OZEM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 18 OZEM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings17.59%LLYEli Lilly and Company$737.56-6.5%4.8973 of 5 stars2.84$1,009.72 36.9%19Gap Down12.79%NVONovo Nordisk A/S$62.58-6.7%4.8028 of 5 stars2.80$145.25 132.1%10Gap Down5.08%AZNAstraZeneca$68.46-7.4%3.5507 of 5 stars3.10$89.75 31.1%10Positive NewsGap Down4.66%AMGNAmgen$294.39-5.0%4.29 of 5 stars2.48$314.04 6.7%23News CoveragePositive News3.65%PFEPfizer$22.99-5.4%4.966 of 5 stars2.63$31.92 38.9%16High Trading Volume2.63%GILDGilead Sciences$107.25-4.6%4.4556 of 5 stars2.72$105.12 -2.0%29Analyst RevisionPositive News2.41%REGNRegeneron Pharmaceuticals$573.45-6.1%4.7326 of 5 stars2.76$966.88 68.6%25Short Interest ↑Analyst RevisionHigh Trading Volume2.41%TAKTakeda Pharmaceutical$14.74-3.0%2.3279 of 5 stars3.001Analyst UpgradeNews CoverageHigh Trading Volume2.33%VKTXViking Therapeutics$22.62-6.6%4.2975 of 5 stars3.00$95.18 320.8%12Positive NewsGap Down2.30%ALTAltimmune$4.24-4.9%2.0564 of 5 stars2.89$20.83 391.4%9Analyst ForecastGap Down2.08%GPCRStructure Therapeutics$15.12-7.4%1.9944 of 5 stars3.00$81.29 437.6%8News CoverageGap Down1.71%RYTMRhythm Pharmaceuticals$46.95-5.8%4.3484 of 5 stars2.92$69.46 47.9%13Positive NewsGap Down1.63%SRRKScholar Rock$26.90-12.4%3.965 of 5 stars3.00$42.67 58.6%6News CoveragePositive NewsGap DownHigh Trading Volume1.58%OPKOPKO Health$1.55-1.3%4.0944 of 5 stars3.00$2.75 77.4%3Insider TradeShort Interest ↑News Coverage1.37%CORTCorcept Therapeutics$74.45-6.2%4.2946 of 5 stars3.00$143.25 92.4%5Analyst ForecastInsider TradeOptions VolumeAnalyst RevisionNews CoverageGap DownHigh Trading Volume1.19%BHVNBiohaven$18.54-9.8%4.0115 of 5 stars3.07$62.77 238.5%15News CoverageGap DownHigh Trading Volume1.15%TERNTerns Pharmaceuticals$2.10-9.9%3.8189 of 5 stars2.60$18.38 775.0%5Gap Down0.18%KROSKeros Therapeutics$9.98-2.9%3.4483 of 5 stars2.57$42.33 324.2%14Analyst ForecastNews CoverageGap DownHigh Trading Volume This page (NYSEARCA:OZEM) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OZEM Stock Free OZEM Stock Alerts